Login to Your Account



Pharma: Other News To Note


Wednesday, March 27, 2013
• GlaxoSmithKline plc, of London, and the Texas A&M University System said the Department of Health and Human Services approved the establishment of a $91 million influenza-vaccines manufacturing facility as the anchor for the Center for Innovation in Advanced Development and Manufacturing in Bryan-College Station, Texas.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription